Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Your donations help support people living with type 1 diabetes today and fund the best treatment and cure research, no matter where in the world it takes place.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
Join our Virtual Triathlon Challenge and swim, cycle and run while raising money to fund Breakthrough T1D’s life-changing type 1 research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > About Breakthrough T1D UK & our impact > Our research
One day, we will create a world without type 1 diabetes. Until that day, your support is vital for our international research to cure, treat and prevent type 1.
We fund international research that will cure, treat and prevent type 1 diabetes and its complications. We focus on investing in research that will transform the lives of people with type 1 diabetes – improving treatments today until we find a cure.
Over 400 active research studies are being funded by Breakthrough T1D UK around the world
Breakthrough T1D UK-funded research is currently taking place in 21 countries
At any one time, Breakthrough T1D UK is funding around 20 research projects in the UK
Discover how we’re working to cure, treat and prevent type 1 diabetes
Our researchers are working on lots of different ways to develop a cure for type 1 diabetes, from growing insulin-producing beta cells in labs to hacking the immune system to stop it attacking beta cells.
We’re improving lives by developing new ways to treat type 1 diabetes, until we find a cure. Our treatment research includes advancing technologies to help people with type 1 manage their blood glucose levels, creating new and improved types of insulin, and tackling diabetes complications.
Our prevention research aims to fix the problems with the immune system that lie at the heart of the condition. We’re also supporting screening projects to find people in the earliest stages of developing type 1 and delay their need for insulin injections.
The US FDA recently approved a drug that can delay the onset of type 1 diabetes for up to three years, called teplizumab. This success wouldn’t have happened without 30 years of Breakthrough T1D UK funding research.
Since 2006, we have funded research to develop and test hybrid closed loop (HCL) technology, which links people's insulin pump to their continuous glucose monitor. Now, HCL is set to become available to many people on the NHS.
For over 20 years, we funded Professor Doug Melton to grow stem cells into insulin-producing beta cells. Doug now works at Vertex Pharmaceuticals, who are running a clinical trial transplanting Doug’s lab-grown beta cells into people with type 1.
Dr Matthew Anson is studying whether hybrid closed loop technology, also known as an artificial pancreas, affects the worsening of diabetic eye disease.
Dr Samet Sahin is developing a simple tool to allow healthcare professionals to quickly and easily check someone’s C-peptide levels, a measure of how much insulin they are releasing.
Dr Thomas George Hill is studying a type of pancreatic islet cell, called a delta cell, which he thinks could be targeted with a treatment to help prevent low blood glucose in type 1 diabetes.
Dr Rebecca Dewhurst-Trigg is investigating how supportive cells called mesenchymal stromal cells may help protect insulin-making beta cells from being destroyed in type 1 diabetes.
Dr Richard Pulsford is developing a visual tool for people with type 1 diabetes that predicts the likelihood of their blood glucose going too low during exercise
Dr Parth Narendran is comparing how effective different treatments are for people newly diagnosed with type 1 diabetes at protecting their remaining insulin-making beta cells.
Dr Mandeep Kaur Marwah is developing a new type of dressing to help diabetic wounds heal more quickly.
Connect Immune Research has launched a first-of-its-kind research project to confront the UK’s high prevalence of autoimmune conditions.
Learn about clinical trials, how to get involved in the different kinds of type 1 diabetes research and view current opportunities.
Dr Rachel Besser, Consultant and Research Lead at Oxfordshire Children’s Diabetes Service, and researcher at the University of Oxford, on how teplizumab being approved in the US benefits children in the UK.
Globally, we have invested over £2 billion in research to date and are currently funding more than 400 research projects and 19 clinical trials. Breakthrough T1D UK has several funding opportunities available that address our mission to cure, treat and prevent type 1 diabetes.
Sana Biotechnology, a US-based biotech company, has released clinical data showing that the first person receiving engineered islets from deceased donors is now producing insulin without the need for immunosuppressive drugs.
Our highlights from a year full of breakthroughs in type 1 diabetes research and advocacy.
We’ve awarded four new grants to UK researchers to help improve lives and develop cures for people living with type 1 diabetes.
The framework aims to encourage UK researchers to consider different sexes (biological attributes) and genders (roles, behaviours and identity in society) to address gaps in health data.
We work with researchers and partner organisations to make sure we can improve life with type 1 diabetes as quickly as possible. Learn about the research we do in partnership with other organisations.
Discover how we work with other organisations to help us make every penny we receive from our amazing supporters go even further to help people with type 1.
Learn about how we're partnering with other autoimmune research funders, pooling our resources to help prevent and cure a range of autoimmune conditions, including type 1 diabetes.
The Type 1 Diabetes Grand Challenge is a partnership between the Steve Morgan Foundation, Diabetes UK and Breakthrough T1D UK. We are united by our ambition to cure type 1 diabetes.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.
